معرفی
Eckardt Treuter is a Professor at Karolinska Institutet, leading the research group 'Epigenetic mechanisms underlying metabolic-inflammatory diseases' in the Department of Medicine, Huddinge. His work focuses on understanding how epigenetic alterations drive metabolic and inflammatory diseases, including obesity, type 2 diabetes, atherosclerosis, and fatty liver disease. He completed his PhD at Martin Luther University Halle-Wittenberg and conducted postdoctoral research at Karolinska Institutet, identifying nuclear receptor-associated proteins.
Research interests include corepressor complexes (e.g., GPS2, HDAC3, NCOR/SMRT) and their roles in metabolic-inflammatory pathways. His team uses molecular biology, genomics, and genetically modified models to explore epigenetic reprogramming and therapeutic targeting strategies.
Key projects involve studying GPS2's role in macrophage activation, atherosclerosis progression, and epigenetic memory between cell types. Recent work highlights GPS2's clinical relevance in systemic inflammation and diabetic risk in obese humans. Grants include funding from the Swedish Research Council and Novo Nordisk Foundation.
- Education: PhD in Molecular Biology (Martin Luther University Halle-Wittenberg), Postdoc at Karolinska Institutet
- Awards: Multiple grants for research on metabolic-inflammatory diseases
Labs/Teams: Leads a multidisciplinary group with collaborations across clinical and basic science domains. Current students include PhD candidates Astradeni Efthymiadou, Sviatlana Sukhanava, and Yue Zhu.
